Paul B. Kusserow's most recent trade in Amedisys Inc. was a trade of 1,690 Common Stock done . Disclosure was reported to the exchange on May 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amedisys Inc. | Paul B. Kusserow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2025 | 1,690 | 439,124 (1%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Paul B. Kusserow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,678 | 353,670 (1%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Paul B. Kusserow | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.88 per share. | 10 Apr 2023 | 16,257 | 351,992 (1%) | 0% | 78.9 | 1,282,352 | Common Stock |
| Amedisys Inc. | Paul B. Kusserow | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 5,777 | 370,523 (1%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Paul B. Kusserow | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 5,777 | 0 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | Paul B. Kusserow | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.00 per share. | 01 Feb 2023 | 2,274 | 368,249 (1%) | 0% | 97 | 220,578 | Common Stock |
| Amedisys Inc. | Paul B. Kusserow | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.60 per share. | 06 Jan 2023 | 6,820 | 413,838 (1%) | 0% | 82.6 | 563,332 | Common Stock |
| Amedisys Inc. | Paul B. Kusserow | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 41,313 | 420,658 (1%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 73,638 | 0 | - | - | Restricted Stock Units | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 49,092 | 398,663 (1%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.25 per share. | 17 Feb 2022 | 9,659 | 379,345 (1%) | 0% | 143.3 | 1,383,652 | Common Stock |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.25 per share. | 17 Feb 2022 | 9,659 | 389,004 (1%) | 0% | 143.3 | 1,383,652 | Common Stock |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2022 | 17,640 | 83,764 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 17,330 | 349,571 (1%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 5,777 | 5,777 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.88 per share. | 02 Jan 2022 | 4,866 | 332,241 (1%) | 0% | 161.9 | 787,708 | Common Stock |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 24,546 | 24,546 | - | - | Restricted Stock Units | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 24,546 | 337,107 (1%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 293.33 per share. | 02 Jan 2021 | 4,848 | 312,561 (0%) | 0% | 293.3 | 1,422,064 | Common Stock |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2020 | 250,000 | 0 | - | - | Stock Option (right to buy) | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2020 | 250,000 | 0 | - | - | Stock Option (right to buy) | |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.65 per share. | 10 Aug 2020 | 250,000 | 299,092 (0%) | 0% | 26.7 | 6,662,500 | Common Stock |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.78 per share. | 10 Aug 2020 | 250,000 | 549,092 (1%) | 0% | 26.8 | 6,695,000 | Common Stock |
| Amedisys Inc. | Paul B. Kusserow | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.92 per share. | 10 Aug 2020 | 231,683 | 317,409 (0%) | 0% | 231.9 | 53,731,921 | Common Stock |